Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01462188
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Marco Valgimigli
- Registry
-
NCT01462188
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01462188. Randomized; single masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2012-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study
- Acronym
- OPTIMASTRATEGY
- Condition
- Myocardial Infarction
- Intervention (Procedure)
- Immediate stenting
- Intervention (Procedure)
- Delayed stenting
- Lead sponsor
- Marco Valgimigli
Record details
- Record id
cardio:ct-nct01462188- Content hash
76954015a2efe565521fb805b162c0878335c214822162209f2dece9ce61dc33